Do epigenetic drug treatments hold the key to killing cancer progenitor cells? | Epigenomics;6(2): 161-5, 2014 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Do epigenetic drug treatments hold the key to killing cancer progenitor cells?

Byler, Shannon; Sarkar, Sibaji.

Affiliation

Byler S; Cancer Center, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Epigenomics ; 6(2): 161-5, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24811783

Subject(s)

DNA Methylation/genetics; Epigenesis, Genetic/genetics; Neoplasms/genetics; Neoplastic Stem Cells/pathology; Cell Differentiation/genetics; Humans; Neoplasms/drug therapy; Neoplastic Stem Cells/drug effects

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / DNA Methylation / Epigenesis, Genetic / Neoplasms Limits: Humans Language: En Journal: Epigenomics Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / DNA Methylation / Epigenesis, Genetic / Neoplasms Limits: Humans Language: En Journal: Epigenomics Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom